Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of UBE3A-ATS expression

Modulation of UBE3A-ATS expression

US Patent 9617539 · Granted Apr 11, 2017

Estimated economic value: $46,700,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for modulating GFAP2025
Conjugated antisense compounds and their use2025
Methods for reducing Ataxin-2 expression2025
Compositions and methods for detection of SMN protein in a subject and treatment2024
Compounds and methods for reducing ATXN2 expression2024
Oligomeric compounds for reducing DMPK expression2023
Compounds and methods for modulating GFAP2023
Methods for treating Alzheimer's disease2023
Compounds and methods for the modulation of amyloid-β precursor protein2023
Conjugated antisense compounds and their use2023
Methods for modulating FMR1 expression2023
Compositions and methods for modulation of SMN2 splicing in a subject2022